Captrust Financial Advisors Immutep LTD Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$2.3 - $3.61 $368 - $577	160 Added 9.41%	1,860 $5,000
Q4 2021 Feb 14, 2022	SELL	$3.09 - $4.81 $30,900 - $48,099	-10,000 Reduced 85.47%	1,700 $6,000
Q3 2021 Nov 16, 2021	BUY	$3.17 - $4.39 $31,700 - $43,900	10,000 Added 588.24%	11,700 $45,000
Q3 2020 Nov 17, 2020	BUY	$1.05 - $1.89 $1,785 - $3,213	1,700 New	1,700 $3,000

2.41M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.